Seshidhar Reddy Police is an accomplished inventor based in Burlington, MA, known for his significant contributions to the field of retinal dystrophy treatment. With a total of five patents to his name, he has made remarkable strides in developing innovative solutions for eye health.

Latest Patents

Among his latest patents, Seshidhar has focused on viral vectors for the treatment of retinal dystrophy. These viral vectors are designed to deliver a heterologous gene to the retina, specifically targeting RLBP1 to retinal pigment epithelium (RPE) and Müller cells. His inventions also encompass nucleic acids that are useful for producing these viral vectors, as well as compositions that include the viral vectors. The methods he has developed aim to enhance the delivery and expression of heterologous genes in the retina, ultimately improving the rate of dark adaptation in subjects and treating RLBP1-associated retinal dystrophy.

Career Highlights

Seshidhar Reddy Police is currently employed at Novartis AG, where he continues to push the boundaries of innovation in medical research. His work has garnered attention for its potential to transform the treatment landscape for retinal diseases.

Collaborations

He collaborates with talented individuals such as Vivian Choi and Chad Eric Bigelow, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Seshidhar Reddy Police's work in developing viral vectors for retinal dystrophy treatment exemplifies the impact of innovative thinking in the medical field. His contributions are paving the way for new therapeutic approaches that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.